Mangalam Drugs And Organics Limited, a active public limited company, was established on 18 April 1972 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L24230MH1972PLC116413. Registered under ROC Roc Mumbai. it is listed on BSE: 532637 and NSE: MANGALAM. It has an authorized capital of ₹30.00 Cr and a paid-up capital of ₹15.83 Cr.
Formerly known as Mangalam Drugs And Organics Private Limited, Advent Pharma Private Limited. It upholds a compliant status. In 2023, it reported revenue of ₹372.69 Cr and a net worth of ₹151.96 Cr. Employing 453 professional, Its leadership includes Rakesh Kishinchand Milwani (Director), Govardhan Murlidhar Dhoot (Managing Director), Praveen Saxena (Director). Past directors included Prashant Jagannath Pandit, Rajendra Prasad Mimani, Rakesh Kishinchand Milwani. It holds ₹251.37 Cr open charges and ₹314.63 Cr settled loans. Its latest AGM occurred on 26 September 2024, with the balance sheet filed on 31 March 2024. It is based at 3Rd Floor, Rupam Building 239, P. D'Mello Road, Mumbai, Maharashtra, 400001.
L24230MH1972PLC116413
116413
18 April 1972
₹30.00 Cr
₹15.83 Cr
Roc Mumbai
Listed (BSE: 532637, NSE: MANGALAM)
Active
Explore comprehensive insights into Mangalam Drugs And Organics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rakesh Kishinchand Milwani | Director | 10 Mar 2022 | Current |
| Govardhan Murlidhar Dhoot | Managing Director | 16 Apr 1996 | Current |
| Praveen Saxena | Director | 21 Mar 2021 | Current |
| Nidhi Shantanu Mundada | Director | 28 May 2018 | Current |
| Brijmohan Murlidhar Dhoot | Whole-Time Director | 02 May 2015 | Current |
| Rukmesh Prabhukumar Dhandhania | Director | 20 Nov 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 25 Sep 2019 | Past |
| Pramod Abcsdd | Director | 03 Feb 2015 | Past |
| Pramod Abcsdd | Additional Director | 14 Apr 2022 | Past |
| Pramod Abcsdd | Whole-Time Director | 01 Nov 2014 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mangalam Drugs And Organics Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.39% decrease. The company also saw a substantial fall in profitability, with a 93.54% decrease in profit. The company's net worth moved up by a moderate rise of 0.69%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Mangalam Drugs And Organics had a promoter holding of 50.31% and a public holding of 49.69%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,513,680,777.00
₹3,146,257,886.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jul 2025 | Others | ₹8.00 Cr | Open |
| 31 May 2025 | Others | ₹1.74 M | Open |
| 29 Jan 2025 | Others | ₹1.50 Cr | Open |
| 05 Dec 2024 | Others | ₹5.44 M | Open |
| 02 Dec 2024 | Others | ₹1.99 Cr | Open |
Explore comprehensive loan charge details -
Mangalam Drugs And Organics has a workforce of 453 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Mangalam Drugs And Organics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mangalam Drugs And Organics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others amounted to Rs. 8.00 Cr with Charge ID 101139790 was registered on 25 Jul 2025. was documented.
The activity A charge registered on 12 Jul 2022 via Charge ID 100601006 with Hdfc Bank Limited was fully satisfied on 17 Jun 2025. was completed.
The activity A charge with Others amounted to Rs. 0.17 Cr with Charge ID 101107592 was registered on 31 May 2025. was completed.
Progress on A charge with Others of Rs. 0.98 Cr registered on 29 Nov 2024 with Charge ID 101014760 was modified on 20 Mar 2025. was documented.
A charge registered on 18 Mar 2021 via Charge ID 100460403 with Others was fully satisfied on 01 Mar 2025. was recorded as a recent event.
A charge registered on 16 Apr 2022 via Charge ID 100570640 with Others was fully satisfied on 27 Feb 2025. was recorded as a recent event.
The CIN of Mangalam Drugs And Organics Limited is L24230MH1972PLC116413.
Mangalam Drugs And Organics Limited is headquartered at 3Rd Floor, Rupam Building 239, P. D'Mello Road, Mumbai, Maharashtra, 400001.
Mangalam Drugs And Organics Limited was incorporated on 18 April 1972.
The current directors of Mangalam Drugs And Organics Limited are
The primary industry of Mangalam Drugs And Organics Limited is Manufacturing.
Mangalam Drugs And Organics Limited is listed. It is listed on BSE: 532637 and NSE: MANGALAM.
The authorized capital of Mangalam Drugs And Organics Limited is ₹30.00 Cr, and the paid-up capital is ₹15.83 Cr.
The compliance status of Mangalam Drugs And Organics Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX